CD8A and neoplasm: Efficient anti-tumor immune response needs that cytotoxic CD8+ T cells recognize and kill cells displaying foreign antigens, like tumor neoantigens, via MHC class I (MHC-I) molecule’s presentation, and it has been shown that downregulation of antigen presentation and MHC-I expression are known resistance mechanisms to ICI [26].